Cambridge, MA, United States of America

Wilma Wasco

This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignees: The General Hospital Corporation, Massachusetts Institute of Technology, Other. Active years: 1998-2002.

USPTO Granted Patents = 4 

% Patents Active = 100.0

Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 39(Granted Patents)


Location History:

  • Boston, MA (US) (1998 - 1999)
  • Cambridge, MA (US) (2001 - 2002)

Company Filing History:


Years Active: 1998-2002

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Wilma Wasco: Innovator in Alzheimer's Disease Research

Introduction

Wilma Wasco is a prominent inventor based in Cambridge, MA (US), known for her significant contributions to the field of Alzheimer's disease research. With a total of 4 patents, she has made remarkable strides in understanding and addressing this complex condition.

Latest Patents

Her latest patents include groundbreaking work on the Chromosome 1 gene and gene products related to Alzheimer's Disease. This invention discloses nucleic acid molecules encoding AD4 gene products, expression vectors, and host cells suitable for expressing such gene products. Additionally, it outlines methods for treating, preventing, and diagnosing Alzheimer's Disease. Another notable patent focuses on genetic alterations related to familial Alzheimer's disease, providing isolated nucleic acid molecules that encode human PS1 gene products. This patent also includes mutant PS1 polypeptides, vectors, host cells, and recombinant methods for producing these elements. Furthermore, it relates to screening methods for identifying agonists and antagonists of the activity of the PS1 polypeptide and mutants thereof, along with diagnostic and therapeutic methods for detecting and treating Alzheimer's disease.

Career Highlights

Throughout her career, Wilma Wasco has worked with esteemed organizations such as The General Hospital Corporation and the Massachusetts Institute of Technology. Her work in these institutions has significantly advanced the understanding of genetic factors in Alzheimer's disease.

Collaborations

Wilma has collaborated with notable colleagues, including Rudolph Emile Tanzi and Keith Bupp, further enhancing her research and contributions to the field.

Conclusion

Wilma Wasco's innovative work in Alzheimer's disease research has led to important patents that contribute to the understanding and potential treatment of this challenging condition. Her dedication to scientific advancement continues to inspire future research in the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…